Log in to save to my catalogue

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10803255

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

About this item

Full title

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2024-01, Vol.30 (1), p.218-228

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Neoadjuvant immunotherapy plus chemotherapy improves event-free survival (EFS) and pathologic complete response (0% residual viable tumor (RVT) in primary tumor (PT) and lymph nodes (LNs)), and is approved for treatment of resectable lung cancer. Pathologic response assessment after neoadjuvant therapy is the potential analog to radiographic respon...

Alternative Titles

Full title

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10803255

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10803255

Other Identifiers

ISSN

1078-8956,1546-170X

E-ISSN

1546-170X

DOI

10.1038/s41591-023-02660-6

How to access this item